Pharmaceuticals and biotechnology
Selected experience includes:
- Providing strategic advice and government engagement support to a specialist international biopharmaceutical company seeking reimbursement for a treatment targeting a rare and life-threatening disorder.
- Working with a global biotechnology company in relation to regulatory and reimbursement approvals for a first-in-line therapy for a rare neuro-muscular disorder.
- Assisting a global biopharmaceutical company to secure a landmark Pharmaceutical Benefits Scheme listing for first-in-class treatment for an infectious disease through execution of a long-term strategic government relations strategy.
For further information on our pharmaceuticals and biotechnology capabilities please contact:
Kirsten Mulley
CEO
+61 408 476 470
Nick Xerakias
Partner
+61 410 417 173
or Contact Us